erythrosine has been researched along with Benign Neoplasms, Brain in 31 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ)." | 7.81 | Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. ( Munoz, JL; Rameshwar, P; Scotto, KW; Walker, ND, 2015) |
| " Such effects should be kept in mind when acyl-derived compounds are used to probe the function of the endocannabinoid system in the CNS, particularly in chronic administration protocols." | 5.33 | Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. ( De Lago, E; Fernández-Ruiz, J; Fowler, CJ; Gustafsson, SB; Jacobsson, SO; Nilsson, J, 2006) |
| "Total resection is the optimal treatment for malignant gliomas." | 5.30 | Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. ( Ishii, H; Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Takeuchi, H, 1997) |
| " Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ)." | 3.81 | Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. ( Munoz, JL; Rameshwar, P; Scotto, KW; Walker, ND, 2015) |
| "85 mL/h), and a long elimination half-life (mean T(1/2;β) = 307 hours)." | 2.76 | Pharmacokinetics of 5-aminofluorescein-albumin, a novel fluorescence marker of brain tumors during surgery. ( Ding, R; Fardanesh, M; Frei, E; Haefeli, WE; Kremer, P; Schrenk, HH, 2011) |
| " Such effects should be kept in mind when acyl-derived compounds are used to probe the function of the endocannabinoid system in the CNS, particularly in chronic administration protocols." | 1.33 | Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. ( De Lago, E; Fernández-Ruiz, J; Fowler, CJ; Gustafsson, SB; Jacobsson, SO; Nilsson, J, 2006) |
| "Total resection is the optimal treatment for malignant gliomas." | 1.30 | Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. ( Ishii, H; Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Takeuchi, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (54.84) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Ozden, M | 1 |
| Mammadkhanli, O | 1 |
| Zaimoglu, M | 1 |
| Bayatli, E | 1 |
| Bozkurt, M | 1 |
| Gielen, PR | 1 |
| Aftab, Q | 1 |
| Ma, N | 1 |
| Chen, VC | 1 |
| Hong, X | 1 |
| Lozinsky, S | 1 |
| Naus, CC | 1 |
| Sin, WC | 1 |
| Munoz, JL | 1 |
| Walker, ND | 1 |
| Scotto, KW | 1 |
| Rameshwar, P | 1 |
| Wu, HB | 1 |
| Wang, Z | 1 |
| Wang, QS | 1 |
| Han, YJ | 1 |
| Wang, M | 1 |
| Zhou, WL | 1 |
| Li, HS | 1 |
| Kremer, P | 2 |
| Fardanesh, M | 2 |
| Ding, R | 2 |
| Pritsch, M | 1 |
| Zoubaa, S | 1 |
| Frei, E | 2 |
| Schrenk, HH | 1 |
| Haefeli, WE | 1 |
| Deleyrolle, LP | 2 |
| Harding, A | 1 |
| Cato, K | 1 |
| Siebzehnrubl, FA | 1 |
| Rahman, M | 1 |
| Azari, H | 2 |
| Olson, S | 1 |
| Gabrielli, B | 1 |
| Osborne, G | 1 |
| Vescovi, A | 1 |
| Reynolds, BA | 2 |
| Rohaus, MR | 1 |
| Fortin, JM | 1 |
| SEAMAN, WB | 1 |
| TER-POGOSSIAN, MM | 1 |
| SCHWARTZ, HG | 1 |
| YANO, K | 1 |
| ULITOVSKII, DA | 1 |
| ORTIZBERROCAL, J | 1 |
| De Lago, E | 1 |
| Gustafsson, SB | 1 |
| Fernández-Ruiz, J | 1 |
| Nilsson, J | 1 |
| Jacobsson, SO | 1 |
| Fowler, CJ | 1 |
| Yoshii, Y | 1 |
| Maki, Y | 1 |
| Egashira, T | 1 |
| Nakagawa, K | 1 |
| Reck, R | 1 |
| Wissen-Siegert, I | 1 |
| Kabuto, M | 1 |
| Kubota, T | 1 |
| Kobayashi, H | 1 |
| Nakagawa, T | 1 |
| Ishii, H | 1 |
| Takeuchi, H | 1 |
| Kitai, R | 1 |
| Kodera, T | 1 |
| Andersson, U | 1 |
| Grankvist, K | 1 |
| Bergenheim, AT | 1 |
| Behnam-Motlagh, P | 1 |
| Hedman, H | 1 |
| Henriksson, R | 1 |
| Kawase, T | 1 |
| Zhang, RD | 1 |
| Price, JE | 1 |
| Fujimaki, T | 1 |
| Bucana, CD | 1 |
| Fidler, IJ | 1 |
| Knott, JC | 1 |
| Edwards, AJ | 1 |
| Gullan, RW | 1 |
| Clarke, TM | 1 |
| Pilkington, GJ | 1 |
| Murakami, M | 1 |
| Ushio, Y | 1 |
| Mihara, Y | 1 |
| Kuratsu, J | 1 |
| Horiuchi, S | 1 |
| Morino, Y | 1 |
| Neuwelt, EA | 1 |
| Frenkel, EP | 1 |
| D'Agostino, AN | 1 |
| Carney, DN | 1 |
| Minna, JD | 1 |
| Barnett, PA | 1 |
| McCormick, CI | 1 |
| Ginsbourg, M | 2 |
| Foncin, JF | 2 |
| Le Beau, J | 2 |
| Sanders, MD | 1 |
| Piovanetti, E | 1 |
| Eckelhoff, R | 1 |
| Haining, WM | 1 |
| Gass, JD | 1 |
| Feindel, W | 1 |
| Yamamoto, YL | 1 |
| Hodge, CP | 1 |
| Wilcke, O | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of Eribulin in Brain Metastases From HER2-negative Breast Cancer Pre-treated With Anthracyclines and Taxanes[NCT03637868] | Phase 2 | 0 participants (Actual) | Interventional | 2019-02-26 | Withdrawn (stopped due to no enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for erythrosine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
[RADIOACTIVE ISOTOPES IN THE NEUROLOGICAL DIAGNOSIS].
Topics: Arsenic; Bismuth; Boron; Brain Neoplasms; Copper; Fluoresceins; Fluorine; Humans; Iodine Isotopes; M | 1963 |
1 trial available for erythrosine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Pharmacokinetics of 5-aminofluorescein-albumin, a novel fluorescence marker of brain tumors during surgery.
Topics: Aged; Brain Neoplasms; Chromatography, Gel; Chromatography, High Pressure Liquid; Female; Fluorescei | 2011 |
29 other studies available for erythrosine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Could Fluorescein Staining in Low-Grade Glial Tumors Guide for Peroperative Differentiation of Pathological Types?
Topics: Astrocytoma; Brain Neoplasms; Fluoresceins; Glioblastoma; Glioma; Humans; Oligodendroglioma; Retrosp | 2023 |
Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
Topics: Analysis of Variance; Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cel | 2013 |
Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells.
Topics: Animals; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; Binding, | 2015 |
Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma.
Topics: Amino Acid Sequence; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Female; Fluoresceins; Fluori | 2015 |
Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Female; Fluoresceins; Glioblastoma; Glioma; Humans | 2009 |
Evidence for label-retaining tumour-initiating cells in human glioblastoma.
Topics: Animals; Antigens, CD; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Differenti | 2011 |
Identification and isolation of slow-dividing cells in human glioblastoma using carboxy fluorescein succinimidyl ester (CFSE).
Topics: Brain Neoplasms; Cell Growth Processes; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glioblastoma | 2012 |
Localization of intracranial neoplasms with radioactive isotopes.
Topics: Brain; Brain Neoplasms; Fluoresceins; Radioisotopes | 1954 |
[Studies on chrome alum hematoxylin-phloxine positive substances in the hypothalumus in intracranial tumor].
Topics: Brain Neoplasms; Coloring Agents; Fluoresceins; Hematoxylin; Humans; Hypothalamus; Staining and Labe | 1962 |
[ON SELECTION OF THE DOSE OF RADIOACTIVE INDICATOR IN RADIOISOTOPE DIAGNOSIS OF BRAIN TUMORS].
Topics: Brain Neoplasms; Diagnostic Techniques, Radioisotope; Fluoresceins; Iodine Isotopes; Radioactivity; | 1963 |
Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
Topics: Acylation; Animals; Antineoplastic Agents; Arachidonic Acids; Benzyl Compounds; Brain; Brain Neoplas | 2006 |
[Experimental study on the application of argon laser photoactivation effect in the treatment of brain tumor].
Topics: Animals; Argon; Brain Neoplasms; Cells, Cultured; Fibrosarcoma; Fluoresceins; Glioma; Humans; Laser | 1983 |
[Results of fluorescein nose endoscopy in the diagnosis of cerebrospinal rhinorrhea].
Topics: Brain Injuries; Brain Neoplasms; Cerebrospinal Fluid Rhinorrhea; Diagnosis, Differential; Endoscopy; | 1984 |
Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration.
Topics: Animals; Astrocytoma; Brain Neoplasms; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Glioblas | 1997 |
Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2002 |
[Study of cerebral microcirculation by serial fluorescein cortical angiography. (Part 2) Pathology and classification of microcirculation].
Topics: Adult; Aged; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluoresceins; Glioblastoma; Gliom | 1977 |
Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Cell Membrane; Cell Membrane Permea | 1992 |
A human glioma cell line retaining expression of GFAP and gangliosides, recognized by A2B5 and LB1 antibodies, after prolonged passage.
Topics: Antibodies, Monoclonal; Astrocytes; Brain Neoplasms; Cell Differentiation; Cell Line; Chromosomes, H | 1990 |
Cholesterol uptake by human glioma cells via receptor-mediated endocytosis of low-density lipoprotein.
Topics: Brain Neoplasms; Carbocyanines; Cholesterol, LDL; Endocytosis; Fluorescein-5-isothiocyanate; Fluores | 1990 |
Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Small Cell; Cell Li | 1985 |
[Studies on the blood-brain barrier with a fluorescent tracer in human brain edema].
Topics: Animals; Blood-Brain Barrier; Brain Damage, Chronic; Brain Edema; Brain Injuries; Brain Neoplasms; F | 1970 |
[Vascular abnormalities in cerebral tumours. A comparative study of enzyme activity and permeability to fluorescent tracers].
Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; | 1973 |
The Foster Kennedy sign.
Topics: Angiography; Brain Neoplasms; Fluoresceins; Frontal Lobe; Fundus Oculi; Humans; Optic Atrophy; Papil | 1972 |
Microcirculatory changes during the evolution of papilledema. A five-stage fluorescein angiographic study of progressive swelling of optic disk in intractable intracranial hypertension.
Topics: Adult; Brain Neoplasms; Capillaries; Fluoresceins; Fundus Oculi; Humans; Male; Melanoma; Microcircul | 1972 |
Diagnostic value of intravenous fluorescein studies.
Topics: Adolescent; Adult; Brain Neoplasms; Diagnosis, Differential; Dye Dilution Technique; Female; Fluores | 1966 |
Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Eye Neoplasms; Female; Fluoresceins; Fu | 1971 |
Red cerebral veins and the cerebral steal syndrome. Evidence from fluorescein angiography and microregional blood flow by radioisotopes during excision of an angioma.
Topics: Arteriovenous Malformations; Blood Circulation Time; Blood Gas Analysis; Brain Neoplasms; Carbon Dio | 1971 |
[Scintigraphy of brain tumors].
Topics: Albumins; Antifibrinolytic Agents; Arsenic; Bismuth; Brain Neoplasms; Copper; Fluoresceins; Gallium; | 1965 |
[Isotope diagnosis in neurosurgery].
Topics: Arsenic; Bismuth; Brain Diseases; Brain Neoplasms; Cerebral Hemorrhage; Cerebrovascular Circulation; | 1966 |